AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Slow and Accelerated Rehabilitation Protocols

RecruitingNAAges 18 Years - 65 YearsAllHacettepe University
💬

In plain words

What the trial is, and whether it could suit you

Latissimus dorsi transfer is an established treatment option with favorable results in massive, irreparable rotator cuff tears, however, it is controversial if earlier motion is detrimental or beneficial to the postoperative goal of reduced pain and improved clinical outcomes. Therefore, the aim of this study is to compare the effects of slow and accelerated rehabilitation protocols after latissimus dorsi transfer in massive, irreparable rotator cuff tears.

Sign in to get the eligibility rules as simple questions to take to your doctor.

📋 Eligibility rules (as published)
Inclusion Criteria: * being in the age range of 18-65 years * being diagnosed with massive, irreparable rotator cuff tears based on magnetic resonance imaging and clinical continuity tests * symptoms are unresponsive to conservative care including steroid injections and physiotherapy for at least 6 months * having a good command of the Turkish language * scoring above 24 in the Mini Mental State Test * ≥80% compliance in completing the post-ARCR Phase 1 trainings * volunteering to participate in the study Exclusion Criteria: * diabetes mellitus * neurological problems * cervical disc herniation * visual, verbal, and/or cognitive defects (aphasia, unilateral neglect, etc.) * systemic inflammatory problems * hypermobility, trauma, and/or inflammation that could be a contraindication for mobilization * former shoulder fractures on the affected side * advanced glenohumeral arthritis (Hamada grade 3), * deltoid muscle dysfunction, * irreparable subscapularis tears, * active infection, * shoulder stiffness, * a history of previous shoulder surgery
💊

What it tests

  • Accelerated (ACCEL) protocol group
  • Slow (SLOW) protocol group
📍

Where

1 site
Kırşehir Ahi Evran University
Kırşehir, Turkey (Türkiye)
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy